80 related articles for article (PubMed ID: 27124943)
1. Effect of Lower Anogenital Squamous Terminology Recommendations on the Use of p16 Immunohistochemistry and the Proportion of High-Grade Diagnoses in Cervical Biopsy Specimens.
Thrall MJ
Am J Clin Pathol; 2016 Apr; 145(4):524-30. PubMed ID: 27124943
[TBL] [Abstract][Full Text] [Related]
2. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
3. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
4. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.
Waxman AG; Chelmow D; Darragh TM; Lawson H; Moscicki AB
Obstet Gynecol; 2012 Dec; 120(6):1465-71. PubMed ID: 23168774
[TBL] [Abstract][Full Text] [Related]
5. The CERTAIN Study Results: Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria.
Wright TC; Stoler MH; Ferenczy A; Ranger-Moore J; Fang Q; Kapadia M; Singh S; Ridder R
Am J Surg Pathol; 2021 Oct; 45(10):1348-1356. PubMed ID: 34232603
[TBL] [Abstract][Full Text] [Related]
6. Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study.
Stoler MH; Wright TC; Ferenczy A; Ranger-Moore J; Fang Q; Kapadia M; Ridder R
Am J Surg Pathol; 2018 Aug; 42(8):1001-1009. PubMed ID: 29697437
[TBL] [Abstract][Full Text] [Related]
7. The terminology of pre-invasive cervical lesions in the UK cervical screening programme.
Herrington CS
Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601
[TBL] [Abstract][Full Text] [Related]
8. Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
Umphress B; Sanchez B; Paintal A; Nayar R; Maniar KP
Am J Surg Pathol; 2018 Apr; 42(4):479-484. PubMed ID: 29438168
[TBL] [Abstract][Full Text] [Related]
9. Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL).
Shain AF; Wilbur DC; Stoler MH; Quade BJ; Kong CS
Int J Gynecol Pathol; 2018 Jan; 37(1):82-87. PubMed ID: 28863068
[TBL] [Abstract][Full Text] [Related]
10. p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.
Sun L; Zhang L; Krigman HR; Hagemann IS
J Low Genit Tract Dis; 2018 Apr; 22(2):104-109. PubMed ID: 29570565
[TBL] [Abstract][Full Text] [Related]
11. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
[TBL] [Abstract][Full Text] [Related]
12. The LAST guidelines in clinical practice: implementing recommendations for p16 use.
Clinton LK; Miyazaki K; Ayabe A; Davis J; Tauchi-Nishi P; Shimizu D
Am J Clin Pathol; 2015 Dec; 144(6):844-9. PubMed ID: 26572990
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
14. Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.
Liu Y; McCluggage WG; Darragh TM; Zheng W; Roberts JM; Park KJ; Hui P; Blakely M; Sigel K; Gaisa MM
Am J Clin Pathol; 2021 May; 155(6):845-852. PubMed ID: 33210115
[TBL] [Abstract][Full Text] [Related]
15. Grading immunohistochemical markers p16
Leeman A; Jenkins D; Marra E; van Zummeren M; Pirog EC; van de Sandt MM; van Eeden A; Schim van der Loeff MF; Doorbar J; de Vries HJC; van Kemenade FJ; Meijer CJLM; Quint WGV
Br J Dermatol; 2020 Apr; 182(4):1026-1033. PubMed ID: 31302935
[TBL] [Abstract][Full Text] [Related]
16. Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines.
Nasierowska-Guttmejer A; Kędzia W; Wojtylak S; Lange D; Rokita W; Jach R; Wielgoś M
Ginekol Pol; 2016; 87(9):670-6. PubMed ID: 27723078
[No Abstract] [Full Text] [Related]
17. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
18. p16 immunostaining in histological grading of anal squamous intraepithelial lesions: a systematic review and meta-analysis.
Albuquerque A; Rios E; Dias CC; Nathan M
Mod Pathol; 2018 Jul; 31(7):1026-1035. PubMed ID: 29434342
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Baruch AC; Silva EG; Jan YJ; Lin E; Sneige N; Deavers MT
Am J Clin Pathol; 2011 Feb; 135(2):212-20. PubMed ID: 21228361
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
